- Home
- Publications
- Publication Search
- Publication Details
Title
Cyclin dependent kinases in cancer
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 13, Issue 7, Pages 451-457
Publisher
Informa UK Limited
Online
2012-05-11
DOI
10.4161/cbt.19589
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular and cellular effects of multi-targeted cyclin-dependent kinase inhibition in myeloma: biological and clinical implications
- (2011) Douglas W. McMillin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Peptides or Small Molecules? Different Approaches to Develop More Effective CDK Inhibitors
- (2011) D. Cirillo et al. CURRENT MEDICINAL CHEMISTRY
- AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition
- (2010) L Santo et al. ONCOGENE
- Future Novel Single Agent and Combination Therapies
- (2009) Diana Cirstea et al. CANCER JOURNAL
- Cyclin-dependent kinase inhibitors as potential targeted anticancer agents
- (2009) Ivan Diaz-Padilla et al. INVESTIGATIONAL NEW DRUGS
- Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma
- (2009) N Raje et al. LEUKEMIA
- Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines
- (2009) M. S. Squires et al. MOLECULAR CANCER THERAPEUTICS
- Cell cycle kinases as therapeutic targets for cancer
- (2009) Silvia Lapenna et al. NATURE REVIEWS DRUG DISCOVERY
- A Novel Therapeutic Combination Using PD 0332991 and Bortezomib: Study in the 5T33MM Myeloma Model
- (2008) E. Menu et al. CANCER RESEARCH
- Phase I Study of Flavopiridol in Combination with Paclitaxel and Carboplatin in Patients with Non–Small-Cell Lung Cancer
- (2008) Saby George et al. Clinical Lung Cancer
- CDK Inhibitors: Cell Cycle Regulators and Beyond
- (2008) Arnaud Besson et al. DEVELOPMENTAL CELL
- Progress in the evaluation of CDK inhibitors as anti-tumor agents
- (2008) C MCINNES DRUG DISCOVERY TODAY
- Identification ofN-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design†
- (2008) Paul G. Wyatt et al. JOURNAL OF MEDICINAL CHEMISTRY
- N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine
- (2008) K. Bettayeb et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started